{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:43:26Z","timestamp":1792806206566,"version":"4.5.0"},"reference-count":132,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.idc.2024.11.008","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T19:44:59Z","timestamp":1733341499000},"page":"121-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Mucormycosis"],"prefix":"10.1016","volume":"39","author":[{"given":"Mary M.","family":"Czech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Cuellar-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.idc.2024.11.008_bib1","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2024.11.008_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.idc.2024.11.008_bib3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/mmy\/myy060","article-title":"A\u00a0prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment","volume":"57","author":"Prakash","year":"2019","journal-title":"Med Mycol"},{"issue":"2","key":"10.1016\/j.idc.2024.11.008_bib4","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001651","article-title":"Mucormycosis-causing fungi in humans: a meta-analysis establishing the phylogenetic relationships using internal transcribed spacer (ITS) sequences","volume":"72","author":"Gunathilaka","year":"2023","journal-title":"J\u00a0Med Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2024.11.008_bib5","first-page":"802","article-title":"Needles in a haystack: extremely rare invasive fungal infections reported in FungiScope(\u24c7)-global registry for emerging fungal infections","volume":"81","author":"Salmanton-Garcia","year":"2020","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.idc.2024.11.008_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1254919","article-title":"Mucormycosis in 2023: an update on pathogenesis and management","volume":"13","author":"Alqarihi","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10.1016\/j.idc.2024.11.008_bib7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/myc.13222","article-title":"Mucormycosis at a tertiary-care center in Mexico. A 35-year retrospective study of 214 cases","volume":"64","author":"Bonifaz","year":"2021","journal-title":"Mycoses"},{"issue":"2","key":"10.1016\/j.idc.2024.11.008_bib8","first-page":"269","article-title":"Mucormycosis in Iran: a six-year retrospective experience","volume":"28","author":"Dolatabadi","year":"2018","journal-title":"J\u00a0Mycol Med"},{"issue":"9","key":"10.1016\/j.idc.2024.11.008_bib9","doi-asserted-by":"crossref","first-page":"e0123021","DOI":"10.1128\/JCM.01230-21","article-title":"Epidemiology and antifungal susceptibilities of mucoralean fungi in clinical samples from the United States","volume":"59","author":"Badali","year":"2021","journal-title":"J\u00a0Clin Microbiol"},{"issue":"10","key":"10.1016\/j.idc.2024.11.008_bib10","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/myc.13123","article-title":"Mucormycosis in the Middle East and North Africa: analysis of the FungiScope((R)) registry and cases from the literature","volume":"63","author":"Stemler","year":"2020","journal-title":"Mycoses"},{"issue":"7","key":"10.1016\/j.idc.2024.11.008_bib11","doi-asserted-by":"crossref","first-page":"944.e9","DOI":"10.1016\/j.cmi.2019.11.021","article-title":"A\u00a0multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India","volume":"26","author":"Patel","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.idc.2024.11.008_bib12","first-page":"26","article-title":"Global epidemiology of mucormycosis","volume":"5","author":"Prakash","year":"2019","journal-title":"J\u00a0Fungi (Basel)"},{"issue":"2","key":"10.1016\/j.idc.2024.11.008_bib13","first-page":"94","article-title":"Mucorales species and macrophages","volume":"6","author":"Nicolas","year":"2020","journal-title":"J\u00a0Fungi (Basel)"},{"key":"10.1016\/j.idc.2024.11.008_bib14","article-title":"Mucormycosis amid COVID-19 crisis: pathogenesis, diagnosis, and novel treatment strategies to combat the spread","volume":"12","author":"Dogra","year":"2021","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.idc.2024.11.008_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/03007995.2020.1846510","article-title":"The disease burden of mucormycosis in Japan: results from a systematic literature review and retrospective database study","volume":"37","author":"Ueno","year":"2021","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.1016\/j.idc.2024.11.008_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/mmy\/myx017","article-title":"Diabetes mellitus as the major risk factor for mucormycosis in Mexico: epidemiology, diagnosis, and outcomes of reported cases","volume":"56","author":"Corzo-Leon","year":"2018","journal-title":"Med Mycol"},{"issue":"8","key":"10.1016\/j.idc.2024.11.008_bib17","first-page":"588","article-title":"Epidemiology of invasive fungal diseases in patients with hematologic malignancies and hematopoietic cell transplantation recipients managed with an antifungal diagnostic driven approach","volume":"7","author":"Bergamasco","year":"2021","journal-title":"J\u00a0Fungi (Basel)"},{"issue":"8","key":"10.1016\/j.idc.2024.11.008_bib18","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.idc.2024.11.008_bib19","doi-asserted-by":"crossref","first-page":"ofaa646","DOI":"10.1093\/ofid\/ofaa646","article-title":"Mucormycosis in hematopoietic cell transplant recipients and in patients with hematological malignancies in the era of new antifungal agents","volume":"8","author":"Miller","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2024.11.008_bib20","first-page":"46","article-title":"Breakthrough invasive fungal infection among patients with haematologic malignancies: a national, prospective, and multicentre study","volume":"87","author":"Puerta-Alcalde","year":"2023","journal-title":"J\u00a0Infect"},{"issue":"1","key":"10.1016\/j.idc.2024.11.008_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/cid\/ciae203","article-title":"Breakthrough invasive fungal infections in patients with high-risk hematological disorders receiving voriconazole and posaconazole prophylaxis: a systematic review","volume":"79","author":"Boutin","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2024.11.008_bib22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/cid\/ciz1127","article-title":"Invasive mold infections after Chimeric antigen receptor-modified T-cell therapy: a case series, review of the literature, and implications for prophylaxis","volume":"71","author":"Haidar","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2024.11.008_bib23","doi-asserted-by":"crossref","first-page":"ofae133","DOI":"10.1093\/ofid\/ofae133","article-title":"The burden of invasive fungal disease following CAR T-cell therapy and strategies for prevention","volume":"11","author":"Little","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2024.11.008_bib24","doi-asserted-by":"crossref","first-page":"ofae043","DOI":"10.1093\/ofid\/ofae043","article-title":"Epidemiology, clinical manifestations, and outcome of mucormycosis in solid organ transplant recipients: a systematic review of reported cases","volume":"11","author":"Palomba","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2024.11.008_bib25","doi-asserted-by":"crossref","first-page":"ofad640","DOI":"10.1093\/ofid\/ofad640","article-title":"Risk factors for invasive fungal infection in lung transplant recipients on universal antifungal prophylaxis","volume":"11","author":"Huggins","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2024.11.008_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13774","article-title":"Mucormycosis in lung transplant recipients: a systematic review of the literature and a case series","volume":"34","author":"Wand","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.idc.2024.11.008_bib27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-3-319-28797-3_15","article-title":"Risks and epidemiology of infections after intestinal transplantation","author":"Soltys","year":"2016","journal-title":"Transplant Infections"},{"issue":"1","key":"10.1016\/j.idc.2024.11.008_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.burns.2022.05.012","article-title":"Mucormycosis following burn injuries: a systematic review","volume":"49","author":"Dang","year":"2023","journal-title":"Burns"},{"issue":"4","key":"10.1016\/j.idc.2024.11.008_bib29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/myc.12897","article-title":"Mucormycosis-A clinicoepidemiological review of cases over 10 years","volume":"62","author":"Manesh","year":"2019","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.idc.2024.11.008_bib30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/mmy\/myz081","article-title":"Mucormycosis due to Apophysomyces species complex- 25 years' experience at a tertiary care hospital in southern India","volume":"58","author":"Pamidimukkala","year":"2020","journal-title":"Med Mycol"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2024.11.008_bib31","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/cid\/cir867","article-title":"Healthcare-associated mucormycosis","volume":"54","author":"Rammaert","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2024.11.008_bib32","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3201\/eid2509.190168","article-title":"Classification of trauma-associated invasive fungal infections to support wound treatment decisions","volume":"25","author":"Ganesan","year":"2019","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2024.11.008_bib33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3201\/eid2003.131230","article-title":"Invasive fungal infections after natural disasters","volume":"20","author":"Benedict","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2024.11.008_bib34","doi-asserted-by":"crossref","first-page":"ofz385","DOI":"10.1093\/ofid\/ofz385","article-title":"Insect bite-associated invasive fungal infections","volume":"6","author":"Kontoyiannis","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"Suppl 5","key":"10.1016\/j.idc.2024.11.008_bib35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1469-0691.2009.02981.x","article-title":"Invasive zygomycosis in neonates and children","volume":"15","author":"Roilides","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"suppl_1","key":"10.1016\/j.idc.2024.11.008_bib36","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1093\/jpids\/pix053","article-title":"Recognition and clinical presentation of invasive fungal disease in neonates and children","volume":"6","author":"King","year":"2017","journal-title":"J\u00a0Pediatric Infect Dis Soc"},{"issue":"1","key":"10.1016\/j.idc.2024.11.008_bib37","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1186\/s12879-016-2005-1","article-title":"Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries","volume":"16","author":"Pana","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2024.11.008_bib38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/myc.12862","article-title":"Invasive mucormycosis in children with cancer: a retrospective study from the infection working group of Italian Pediatric Hematology Oncology Association","volume":"62","author":"Muggeo","year":"2019","journal-title":"Mycoses"},{"issue":"8","key":"10.1016\/j.idc.2024.11.008_bib39","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","article-title":"COVID-19-associated fungal infections","volume":"7","author":"Hoenigl","year":"2022","journal-title":"Nat Microbiol"},{"issue":"9","key":"10.1016\/j.idc.2024.11.008_bib40","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.3201\/eid2709.210934","article-title":"Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India","volume":"27","author":"Patel","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2024.11.008_bib41","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s11046-023-00785-3","article-title":"COVID-19 associated rhino-orbital-cerebral mucormycosis: clinical features, antifungal susceptibility, management and outcome in a tertiary hospital in Iran","volume":"188","author":"Abdorahimi","year":"2023","journal-title":"Mycopathologia"},{"issue":"1","key":"10.1016\/j.idc.2024.11.008_bib42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/myc.13379","article-title":"Results from a national survey on COVID-19-associated mucormycosis in Germany: 13 patients from six tertiary hospitals","volume":"65","author":"Seidel","year":"2022","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.idc.2024.11.008_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-47231-4","article-title":"Absence of COVID-19 associated mucormycosis in a tertiary intensive care unit in The Netherlands","volume":"13","author":"Schippers","year":"2023","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.idc.2024.11.008_bib44","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries","volume":"3","author":"Hoenigl","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.idc.2024.11.008_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.953750","article-title":"Evaluation of environmental Mucorales contamination in and around the residence of COVID-19-associated mucormycosis patients","volume":"12","author":"Ghosh","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.idc.2024.11.008_bib46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jhin.2022.01.016","article-title":"Evaluation of hospital environment for presence of Mucorales during COVID-19-associated mucormycosis outbreak in India - a multi-centre study","volume":"122","author":"Biswal","year":"2022","journal-title":"J\u00a0Hosp Infect"},{"issue":"3","key":"10.1016\/j.idc.2024.11.008_bib47","article-title":"COVID-19-associated mucormycosis in India: why such an outbreak?","volume":"33","author":"Pasquier","year":"2023","journal-title":"J\u00a0Mycol Med"},{"issue":"8","key":"10.1016\/j.idc.2024.11.008_bib48","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/S2213-2600(21)00265-4","article-title":"Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?","volume":"9","author":"Raut","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.idc.2024.11.008_bib49","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cmi.2023.03.008","article-title":"COVID-19-associated mucormycosis: a systematic review and meta-analysis of 958 cases","volume":"29","author":"Ozbek","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idc.2024.11.008_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105388","article-title":"Gastrointestinal mucormycosis: a periodic systematic review of case reports from 2015 to 2021","volume":"163","author":"Didehdar","year":"2022","journal-title":"Microb Pathog"},{"key":"10.1016\/j.idc.2024.11.008_bib51","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.wneu.2018.10.218","article-title":"Diagnosis and treatment of isolated cerebral mucormycosis: patient-level data meta-analysis and Mayo Clinic Experience","volume":"123","author":"Kerezoudis","year":"2019","journal-title":"World Neurosurg"},{"issue":"1","key":"10.1016\/j.idc.2024.11.008_bib52","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1186\/s12879-022-07564-3","article-title":"Isolated splenic mucormycosis secondary to diabetic ketoacidosis: a case report","volume":"22","author":"Luo","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2024.11.008_bib53","doi-asserted-by":"crossref","first-page":"e245309","DOI":"10.1136\/bcr-2021-245309","article-title":"Isolated unilateral renal mucormycosis in a young immunocompetent male","volume":"14","author":"Parmar","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"14","key":"10.1016\/j.idc.2024.11.008_bib54","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.12998\/wjcc.v11.i14.3295","article-title":"Chronic pulmonary mucormycosis caused by rhizopus microsporus mimics lung carcinoma in an immunocompetent adult: a case report","volume":"11","author":"Guo","year":"2023","journal-title":"World J Clin Cases"},{"issue":"3\u20134","key":"10.1016\/j.idc.2024.11.008_bib55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11046-015-9908-z","article-title":"Changing epidemiology of mucoralean fungi: chronic cutaneous infection caused by mucor irregularis","volume":"180","author":"Chander","year":"2015","journal-title":"Mycopathologia"},{"issue":"1","key":"10.1016\/j.idc.2024.11.008_bib56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11046-023-00808-z","article-title":"Mixed aspergillosis and mucormycosis infections in patients with COVID-19: case series and literature review","volume":"189","author":"Sasani","year":"2024","journal-title":"Mycopathologia"},{"issue":"1","key":"10.1016\/j.idc.2024.11.008_bib57","article-title":"Fatal mucormycosis and aspergillosis coinfection associated with haemophagocytic lymphohistiocytosis: a case report and literature review","volume":"33","author":"Loubet","year":"2023","journal-title":"J\u00a0Mycol Med"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2024.11.008_bib58","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2024.11.008_bib59","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/ICU.0000000000000892","article-title":"Rhino-orbital mucormycosis","volume":"33","author":"Ryu","year":"2022","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"10.1016\/j.idc.2024.11.008_bib60","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1148\/rg.2020190156","article-title":"Pulmonary mucormycosis: risk factors, radiologic findings, and pathologic Correlation","volume":"40","author":"Agrawal","year":"2020","journal-title":"Radiographics"},{"issue":"5","key":"10.1016\/j.idc.2024.11.008_bib61","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/cid\/cit929","article-title":"The reversed halo sign: pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia?","volume":"58","author":"Legouge","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2024.11.008_bib62","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/cid\/civ154","article-title":"High resolution computed tomography angiography improves the radiographic diagnosis of invasive mold disease in patients with hematological malignancies","volume":"60","author":"Stanzani","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2024.11.008_bib63","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CMR.13.2.236","article-title":"Zygomycetes in human disease","volume":"13","author":"Ribes","year":"2000","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"10.1016\/j.idc.2024.11.008_bib64","doi-asserted-by":"crossref","first-page":"e0103222","DOI":"10.1128\/jcm.01032-22","article-title":"A\u00a0practical workflow for the identification of Aspergillus, Fusarium, mucorales by MALDI-TOF MS: database, medium, and incubation optimization","volume":"60","author":"Barker","year":"2022","journal-title":"J\u00a0Clin Microbiol"},{"issue":"4","key":"10.1016\/j.idc.2024.11.008_bib65","doi-asserted-by":"crossref","first-page":"myac027","DOI":"10.1093\/mmy\/myac027","article-title":"Evaluation of the Vitek Ms system for the identification of filamentous fungi","volume":"60","author":"Zvezdanova","year":"2022","journal-title":"Med Mycol"},{"issue":"6","key":"10.1016\/j.idc.2024.11.008_bib66","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2024.11.008_bib67","doi-asserted-by":"crossref","first-page":"810 e1","DOI":"10.1016\/j.cmi.2015.12.006","article-title":"Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF)","volume":"22","author":"Millon","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.idc.2024.11.008_bib68","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/cid\/ciab1066","article-title":"Evaluation of serum mucorales polymerase chain reaction (PCR) for the diagnosis of mucormycoses: the MODIMUCOR prospective trial","volume":"75","author":"Millon","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2024.11.008_bib69","doi-asserted-by":"crossref","first-page":"myae030","DOI":"10.1093\/mmy\/myae030","article-title":"Use of the Mucorales qPCR on blood to screen high-risk hematology patients is associated with better survival","volume":"62","author":"Bellanger","year":"2024","journal-title":"Med Mycol"},{"issue":"2","key":"10.1016\/j.idc.2024.11.008_bib70","doi-asserted-by":"crossref","first-page":"myae006","DOI":"10.1093\/mmy\/myae006","article-title":"Performance of Mucorales spp. qPCR in bronchoalveolar lavage fluid for the diagnosis of pulmonary mucormycosis","volume":"62","author":"Brousse","year":"2024","journal-title":"Med Mycol"},{"issue":"8","key":"10.1016\/j.idc.2024.11.008_bib71","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00289-18","article-title":"Quantitative PCR (qPCR) detection of mucorales DNA in bronchoalveolar lavage fluid to diagnose pulmonary mucormycosis","volume":"56","author":"Scherer","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"issue":"2","key":"10.1016\/j.idc.2024.11.008_bib72","first-page":"311","article-title":"Evaluation of MucorGenius(R) mucorales PCR assay for the diagnosis of pulmonary mucormycosis","volume":"81","author":"Guegan","year":"2020","journal-title":"J\u00a0Infect"},{"issue":"9","key":"10.1016\/j.idc.2024.11.008_bib73","doi-asserted-by":"crossref","first-page":"myad091","DOI":"10.1093\/mmy\/myad091","article-title":"Diagnosis of mucormycosis using a simple duplex PCR assay: analysis of 160 clinical samples from COVID-19 patients","volume":"61","author":"Aboutalebian","year":"2023","journal-title":"Med Mycol"},{"issue":"12","key":"10.1016\/j.idc.2024.11.008_bib74","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/myc.12837","article-title":"Identification of Mucorales in patients with proven invasive mucormycosis by polymerase chain reaction in tissue samples","volume":"61","author":"Gholinejad-Ghadi","year":"2018","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.idc.2024.11.008_bib75","first-page":"268","article-title":"Introduction of a comprehensive diagnostic and interdisciplinary management approach in haematological patients with mucormycosis: a pre and post-intervention analysis","volume":"6","author":"Risum","year":"2020","journal-title":"J\u00a0Fungi (Basel)"},{"issue":"3","key":"10.1016\/j.idc.2024.11.008_bib76","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/mmy\/myy041","article-title":"Identification of Aspergillus and Mucorales in formalin-fixed, paraffin-embedded tissue samples: comparison of specific and broad-range fungal qPCR assays","volume":"57","author":"Springer","year":"2019","journal-title":"Med Mycol"},{"issue":"4","key":"10.1016\/j.idc.2024.11.008_bib77","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13656","article-title":"Intestinal mucormycosis initially identified by next-generation sequencing of cell-free DNA","volume":"23","author":"Martin-Blais","year":"2021","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2024.11.008_bib78","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jiac.2021.12.007","article-title":"Aggressive disseminated Rhizomucor pusillus infection in a Ph-like acute lymphoblastic leukemia patient: early detection by cell-free DNA next-generation sequencing","volume":"28","author":"Shi","year":"2022","journal-title":"J\u00a0Infect Chemother"},{"issue":"4","key":"10.1016\/j.idc.2024.11.008_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e25840","article-title":"Rhizopus microsporus and Mucor racemosus coinfection following COVID-19 detected by metagenomics next-generation sequencing: a case of disseminated mucormycosis","volume":"10","author":"Hai","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.idc.2024.11.008_bib80","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13954","article-title":"Cell-free next-generation sequencing impacts diagnosis and antimicrobial therapy in immunocompromised hosts: a retrospective study","volume":"25","author":"Vissichelli","year":"2023","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2024.11.008_bib81","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/cid\/ciab324","article-title":"Plasma microbial cell-free DNA next-generation sequencing in the diagnosis and management of febrile neutropenia","volume":"74","author":"Benamu","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2024.11.008_bib82","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jmii.2023.11.002","article-title":"Diagnostic performance and clinical impacts of metagenomic sequencing after allogeneic hematopoietic stem cell transplantation","volume":"57","author":"Xu","year":"2024","journal-title":"J\u00a0Microbiol Immunol Infect"},{"issue":"11","key":"10.1016\/j.idc.2024.11.008_bib83","doi-asserted-by":"crossref","first-page":"e3876","DOI":"10.1093\/cid\/ciaa1639","article-title":"Liquid biopsy for invasive mold infections in hematopoietic cell transplant recipients with pneumonia through next-generation sequencing of microbial cell-free DNA in plasma","volume":"73","author":"Hill","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2024.11.008_bib84","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/infdis\/jiad255","article-title":"Serial quantitation of plasma microbial cell-free DNA before and after diagnosis of pulmonary invasive mold infections after hematopoietic cell transplant","volume":"229","author":"Heldman","year":"2024","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2024.11.008_bib85","doi-asserted-by":"crossref","first-page":"e0355323","DOI":"10.1128\/spectrum.03553-23","article-title":"Clinical impact of metagenomic next-generation sequencing of peripheral blood for the diagnosis of invasive mucormycosis: a single-center retrospective study","volume":"12","author":"Wang","year":"2024","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10.1016\/j.idc.2024.11.008_bib86","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/14737159.2023.2233906","article-title":"The potential for rapid antigen testing for mucormycosis in the context of COVID-19","volume":"24","author":"Thornton","year":"2024","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.idc.2024.11.008_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1305662","article-title":"Development of a monoclonal antibody and a lateral-flow device for the rapid detection of a Mucorales-specific biomarker","volume":"13","author":"Thornton","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10.1016\/j.idc.2024.11.008_bib88","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2024.11.008_bib89","doi-asserted-by":"crossref","first-page":"ofad704","DOI":"10.1093\/ofid\/ofad704","article-title":"A\u00a0systematic review of the therapeutic outcome of mucormycosis","volume":"11","author":"Sigera","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2024.11.008_bib90","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/myc.13082","article-title":"Treatment of invasive fungal diseases in cancer patients-revised 2019 recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)","volume":"63","author":"Ruhnke","year":"2020","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.idc.2024.11.008_bib91","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.idc.2024.11.008_bib92","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijantimicag.2019.01.002","article-title":"Contemporary management and clinical outcomes of mucormycosis: a systematic review and meta-analysis of case reports","volume":"53","author":"Jeong","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"10.1016\/j.idc.2024.11.008_bib93","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/BF01691218","article-title":"Role of granulocyte colony-stimulating factor in the treatment of mucormycosis","volume":"15","author":"Sahin","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2024.11.008_bib94","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bjh.14597","article-title":"Granulocyte transfusions in the management of invasive fungal infections","volume":"177","author":"West","year":"2017","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.idc.2024.11.008_bib95","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1111\/j.1600-6143.2006.01496.x","article-title":"Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature","volume":"6","author":"Almyroudis","year":"2006","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.idc.2024.11.008_bib96","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2024.11.008_bib97","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/cid\/cir880","article-title":"A\u00a0global analysis of mucormycosis in France: the RetroZygo Study (2005-2007)","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2024.11.008_bib98","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/myc.13538","article-title":"Mucormycosis caused by Apophysomyces species: an experience from a tertiary care hospital in Western India and systematic review of global cases","volume":"66","author":"Samaddar","year":"2023","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.idc.2024.11.008_bib99","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1111\/crj.12724","article-title":"Report of 12 cases with tracheobronchial mucormycosis and a review","volume":"12","author":"He","year":"2018","journal-title":"Clin Respir J"},{"issue":"7","key":"10.1016\/j.idc.2024.11.008_bib100","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14689","article-title":"Outcomes after lung resection in renal transplant patients with pulmonary mucormycosis","volume":"36","author":"Seth","year":"2022","journal-title":"Clin Transplant"},{"issue":"10","key":"10.1016\/j.idc.2024.11.008_bib101","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/myc.12954","article-title":"Cut it out! Thoracic surgeon's approach to pulmonary mucormycosis and the role of surgical resection in survival","volume":"62","author":"Multani","year":"2019","journal-title":"Mycoses"},{"issue":"9","key":"10.1016\/j.idc.2024.11.008_bib102","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1111\/j.1600-6143.2009.02754.x","article-title":"Pulmonary zygomycosis in solid organ transplant recipients in the current era","volume":"9","author":"Sun","year":"2009","journal-title":"Am J Transplant"},{"issue":"Suppl 3","key":"10.1016\/j.idc.2024.11.008_bib103","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/myc.12234","article-title":"Molecular characterization and in\u00a0vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India","volume":"57","author":"Chowdhary","year":"2014","journal-title":"Mycoses"},{"issue":"8","key":"10.1016\/j.idc.2024.11.008_bib104","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00653-19","article-title":"A\u00a0revised species concept for opportunistic mucor species reveals species-specific antifungal susceptibility profiles","volume":"63","author":"Wagner","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.idc.2024.11.008_bib105","first-page":"271","article-title":"In\u00a0vitro antifungal drug resistance profiles of clinically relevant members of the mucorales (mucoromycota) especially with the newer triazoles","volume":"7","author":"Borman","year":"2021","journal-title":"J\u00a0Fungi (Basel)"},{"issue":"2","key":"10.1016\/j.idc.2024.11.008_bib106","first-page":"241","article-title":"Antifungal activity of isavuconazole and comparator agents against Contemporaneous mucorales isolates from USA, Europe, and Asia-Pacific","volume":"9","author":"Carvalhaes","year":"2023","journal-title":"J\u00a0Fungi (Basel)"},{"issue":"1","key":"10.1016\/j.idc.2024.11.008_bib107","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/JCM.06133-11","article-title":"Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales","volume":"50","author":"Vitale","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"11","key":"10.1016\/j.idc.2024.11.008_bib108","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/jac\/dkv236","article-title":"Prospective pilot study of high-dose (10\u00a0mg\/kg\/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis","volume":"70","author":"Lanternier","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.idc.2024.11.008_bib109","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jac\/dkr375","article-title":"The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial","volume":"67","author":"Spellberg","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.idc.2024.11.008_bib110","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/myc.13591","article-title":"Treatment of pulmonary mucormycosis with adjunctive nebulized amphotericin B (MUCONAB trial): results of an open-label randomized controlled trial","volume":"66","author":"Muthu","year":"2023","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.idc.2024.11.008_bib111","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/1040841X.2012.711741","article-title":"Mucormycosis treated with posaconazole: review of 96 case reports","volume":"39","author":"Vehreschild","year":"2013","journal-title":"Crit Rev Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2024.11.008_bib112","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s40001-021-00602-x","article-title":"Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole","volume":"26","author":"Yuan","year":"2021","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.idc.2024.11.008_bib113","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijid.2016.12.014","article-title":"Cerebral rhizomucor infection treated by posaconazole delayed-release tablets in an allogeneic stem cell transplant recipient","volume":"55","author":"Andrey","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2024.11.008_bib114","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cmi.2023.06.017","article-title":"Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis: a prospective cohort study","volume":"29","author":"Manesh","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idc.2024.11.008_bib115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijid.2022.04.009","article-title":"Posaconazole or isavuconazole as sole or predominant antifungal therapy for COVID-19-associated mucormycosis. A retrospective observational case series","volume":"120","author":"Soman","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2024.11.008_bib116","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1093\/jac\/dkz344","article-title":"Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn)","volume":"74","author":"Salmanton-Garcia","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.idc.2024.11.008_bib117","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"10020","key":"10.1016\/j.idc.2024.11.008_bib118","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.idc.2024.11.008_bib119","doi-asserted-by":"crossref","first-page":"e1380","DOI":"10.1093\/cid\/ciab386","article-title":"Isavuconazole treatment of invasive fungal sinusitis: a post hoc analysis of the SECURE and VITAL trials","volume":"73","author":"Durand","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2024.11.008_bib120","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/mmy\/myz103","article-title":"Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system","volume":"58","author":"Schwartz","year":"2020","journal-title":"Med Mycol"},{"issue":"4","key":"10.1016\/j.idc.2024.11.008_bib121","doi-asserted-by":"crossref","first-page":"myad033","DOI":"10.1093\/mmy\/myad033","article-title":"Context of instauration and evolution under isavuconazole, a 2-year prospective real-life study","volume":"61","author":"Pieragostini","year":"2023","journal-title":"Med Mycol"},{"issue":"3","key":"10.1016\/j.idc.2024.11.008_bib122","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/TP.0000000000004312","article-title":"Isavuconazole for the treatment of invasive mold disease in solid organ transplant recipients: a multicenter study on efficacy and safety in real-life clinical practice","volume":"107","author":"Fernandez-Ruiz","year":"2023","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.idc.2024.11.008_bib123","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/cid\/ciz282","article-title":"Isavuconazole prophylaxis in patients with hematologic malignancies and hematopoietic cell transplant recipients","volume":"70","author":"Fontana","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2024.11.008_bib124","first-page":"217","article-title":"Breakthrough mucormycosis developing on mucorales-active antifungals portrays a poor prognosis in patients with hematologic cancer","volume":"7","author":"Axell-House","year":"2021","journal-title":"J\u00a0Fungi (Basel)"},{"issue":"3","key":"10.1016\/j.idc.2024.11.008_bib125","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/589857","article-title":"Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"Reed","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2024.11.008_bib126","doi-asserted-by":"crossref","first-page":"ofae103","DOI":"10.1093\/ofid\/ofae103","article-title":"Combination antifungal therapy for invasive mucormycosis in immunocompromised hosts: a single-center experience","volume":"11","author":"Lu","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idc.2024.11.008_bib127","first-page":"ofac492","article-title":"Efficacy assessment of MAT2203 encochleated oral formulation of amphotericin B, in the neutropenic mouse model of pulmonary mucormycosis","volume":"15","author":"Gebremariam","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2024.11.008_bib128","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00390-17","article-title":"Prophylactic treatment with VT-1161 protects immunosuppressed mice from rhizopus arrhizus var. arrhizus infection","volume":"61","author":"Gebremariam","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.idc.2024.11.008_bib129","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.1128\/AAC.01437-15","article-title":"VT-1161 protects immunosuppressed mice from rhizopus arrhizus var. arrhizus infection","volume":"59","author":"Gebremariam","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.idc.2024.11.008_bib130","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1128\/AAC.00291-11","article-title":"In\u00a0vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds","volume":"55","author":"Miyazaki","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2024.11.008_bib131","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/jac\/dkz022","article-title":"In\u00a0vitro activity of APX001A against rare moulds using EUCAST and CLSI methodologies","volume":"74","author":"Rivero-Menendez","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.idc.2024.11.008_bib132","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00178-20","article-title":"Fosmanogepix (APX001) is effective in the treatment of pulmonary murine mucormycosis due to rhizopus arrhizus","volume":"64","author":"Gebremariam","year":"2020","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552024000837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552024000837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T11:09:51Z","timestamp":1749553791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552024000837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":132,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0891552024000837"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2024.11.008","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucormycosis","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2024.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}